Bladder Exstrophy
10
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Concomitant Renal and Urinary Bladder Allograft Transplantation
Pelvic Osteotomy in Bladder Exstrophy
Long-term Outcomes of Patients Treated for Bladder Exstrophy by Questionnaires.
Prospective Cohort of Transitional Urology Patients
Navigation of the Pelvic Floor in Bladder Exstrophy Using Pre-operative MRI
EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENCE THERAPY BALLOONS IN BLADDER EXSTROPHY AND INCONTINENT EPISPADIAS PATIENTS
Outcome Of Classic Bladder Exstrophy Repair, Assiut University Experience
Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence
Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy